- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Bone mineral testing device gains approval
Alara of Hayward, CA, has received 510(k) clearance from the FDA to market Alara MetriScan, a tabletop device that allows physicians to perform in-office bone and mineral density testing on patients at risk for osteoporosis and related bone
Alara of Hayward, CA, has received 510(k) clearance from the FDA to market Alara MetriScan, a tabletop device that allows physicians to perform in-office bone and mineral density testing on patients at risk for osteoporosis and related bone fracture.
The device scans a patients phalanges to estimate bone mineral density, which can be a predictor of osteoporosis and hip fracture risk.
The Alara MetriScan is a digital radiographic imaging device that uses storage phosphor technology to replace x-ray film as a radiation detector. Total radiation exposure to the patient is less than 5% of a typical dental x-ray, the firm says.
Alara is a privately held medical technology company that designs, manufactures, and markets medical imaging products based on storage phosphor technology.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
